Ameriprise’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.2M | Sell |
|
|||||
|
2025
Q2 | $13M | Buy |
|
|||||
|
2025
Q1 | $10.2M | Sell |
|
|||||
|
2024
Q4 | $28.2M | Buy |
|
|||||
|
2024
Q3 | $24.8M | Buy |
|
|||||
|
2024
Q2 | $30.1M | Buy |
|
|||||
|
2024
Q1 | $31.2M | Sell |
|
|||||
|
2023
Q4 | $33.9M | Buy |
|
|||||
|
2023
Q3 | $13.4M | Buy |
|
|||||
|
2023
Q2 | $12.9M | Buy |
|
|||||
|
2023
Q1 | $5.26M | Buy |
|
|||||
|
2022
Q4 | $2.98M | Buy |
|
|||||
|
2022
Q3 | $3.86M | Sell |
|
|||||
|
2022
Q2 | $8.08M | Buy |
|
|||||
|
2022
Q1 | $8.62M | Buy |
|
|||||
|
2021
Q4 | $7.88M | Sell |
|
|||||
|
2021
Q3 | $6.68M | Buy |
|
|||||
|
2021
Q2 | $8.48M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $589K | Sell |
|
|||||
|
2019
Q3 | $494K | Sell |
|
|||||
|
2019
Q2 | $2.23M | Buy |
|
|||||
|
2019
Q1 | $937K | Buy |
|